EP2429995
Arýlpýrídín sem aldósterónsýnþasahemlar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.5.2010EP published:
22.1.2014EP application number:
10719758.4
EP translation filed:
14.4.2014Grant published:
15.5.2014EPO information:
European Patent Register
Max expiry date:
11.5.2030Expiry date:
11.5.2015
Title:
ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS
Timeline
Today
12.5.2010EP application
22.1.2014EP Publication
14.4.2014Translation submitted
15.5.2014Registration published
11.5.2015Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
CHAMOIN, SylvieAddress:
Basel, CH
Name:
HU, Qi-YingAddress:
Cambridge, Massachusetts, US
Name:
PAPILLON, JulienAddress:
Cambridge, Massachusetts, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
178677 PDate:
15.5.2009Country:
US
Number:
318413 PDate:
29.3.2010Country:
US
Classification
Categories:
C07D 213/76, A61K 31/4418, A61P 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.5.2014
Expires: 11.5.2015
Payer: Árnason Faktor